Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Arcutis, Ashvattha, Ausper, Brii, Cognition, Gri, GSK, Neurocrine, Revolution Medicines, SCG Cell Therapy, Syndax, Telix, Transcode, Viatris, Yamo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dariohealth, Laborie Medical, Mictrostransponder, Novorad, Openwater.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altesa, Astrazeneca, Beacon, Crispr, Daewon, Daiichi Sankyo, Dr. Falk, Gilead, Ipsen, Marea, Perfuse, Phio, Theriva, Tiumbio, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Livanova, Neptune Medical, Smith+Nephew.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, Aldeyra, Cantargia, Celldex, Ferring, OSE, Redx, Tharimmune, Thetis, Tiziana, Topas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Helio Genomics, Heartflow, Ibex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptose, Chemomab, Eupraxia, Immutep, Janus, J&J, Nanobiotix, Opus, PTC, Recursion, Regeneration, Spyre, Theralase, Unity.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Alterity, Chemomab, Yoltech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Elekta, Endospan, Merit Medical, Natera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AN2, Astrazeneca, Transcode.